ARMEN GARO H
EXEC. CHAIR & PRINCIPAL OFFSEC Form 4 insider transaction history, cleaned and classified by FilingIQ.
Total trades
81
Last 180 days
13
Last trade
Aug 21, 2026
Recent tickers traded
Latest filings by ARMEN GARO H
PTIX Protagenic Therapeutics, Inc.\new
P Aug 21, 2026
PTIX Protagenic Therapeutics, Inc.\new
P Aug 20, 2026
PTIX Protagenic Therapeutics, Inc.\new
P Aug 19, 2026
PTIX Protagenic Therapeutics, Inc.\new
P Aug 11, 2026
PTIX Protagenic Therapeutics, Inc.\new
P Aug 6, 2026
Most recent disclosures. Sign up to filter by transaction code, company or dollar value.
Activity overview
FilingIQ has indexed 81 SEC Form 4 insider transactions associated with ARMEN GARO H. The most recent transaction is dated Aug 21, 2026.
Frequently asked
- How many Form 4 transactions has ARMEN GARO H filed?
- FilingIQ has indexed 81 SEC Form 4 insider transactions associated with ARMEN GARO H. The most recent transaction is dated Aug 21, 2026. Every filing sources back directly to SEC EDGAR.
- What does FilingIQ show for ARMEN GARO H's trades?
- Each open-market purchase and sale carries the same seven facts: its size in ARMEN GARO H's own history at that company, the change in holdings, the previous trade, other insiders at the company in the 30 days before, the Rule 10b5-1 plan answer, the reporting time and other companies. FilingIQ does not rate the trades. The rules are at /methodology.
- Which companies has ARMEN GARO H traded?
- Most recent trading activity covers AGEN, PTIX. The full Form 4 history including older issuers is available on the FilingIQ web app.
- Where does FilingIQ's insider data come from?
- Every Form 4 transaction shown on this page is parsed directly from SEC EDGAR XML filings. Insider identity is normalized across CIK changes, name spellings, and indirect / related-party reporting.
Methodology & sources
All Form 4 transactions parsed directly from public SEC EDGAR XML filings. How lines are classified and which facts FilingIQ adds is documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.